A “Real World” Trial to determine efficacy and health outcomes of TOUJEO compared to “standard of care” basal insulins in insulin naïve patients intiating insulin

To demonstrate non-inferiority of Toujeo versus “standard of care” basal insulin therapy measured as glycosylated hemoglobin (HbA1c) change.